Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	GAPVD1 ARHGEF1 PSD3 ARHGEF12 AKAP13 C9orf72 DIS3	7.26e-05	231	88	7	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ARHGAP5 ARHGAP32 GAPVD1 ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 C9orf72 DIS3	7.81e-05	507	88	10	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ARHGAP5 ARHGAP32 GAPVD1 ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 C9orf72 DIS3	7.81e-05	507	88	10	GO:0030695
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BAZ2A BRD7 TAF1L	3.08e-04	30	88	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BAZ2A BRD7 TAF1L	3.40e-04	31	88	3	GO:0140033
GeneOntologyCellularComponent	cell cortex	ARHGAP32 DST EXOC6B AKAP13 PRKD1 MYZAP WDPCP AKAP12 ITPR2	2.19e-05	371	86	9	GO:0005938
GeneOntologyCellularComponent	supramolecular fiber	DST MAP2 SYNJ2 SYNE2 ASPM AKAP13 CEP295 PRKD1 ODF2 CMYA5 MYZAP ZNF804A FKBP4 MEFV AHNAK2	8.48e-05	1179	86	15	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	DST MAP2 SYNJ2 SYNE2 ASPM AKAP13 CEP295 PRKD1 ODF2 CMYA5 MYZAP ZNF804A FKBP4 MEFV AHNAK2	9.15e-05	1187	86	15	GO:0099081
GeneOntologyCellularComponent	ruffle	ARAP3 MAP2 SYNJ2 PSD3 FRMD4B MEFV	2.08e-04	206	86	6	GO:0001726
GeneOntologyCellularComponent	microtubule	DST MAP2 SYNJ2 ASPM CEP295 ODF2 ZNF804A FKBP4 MEFV	3.43e-04	533	86	9	GO:0005874
GeneOntologyCellularComponent	Z disc	DST SYNE2 PRKD1 MYZAP AHNAK2	4.00e-04	151	86	5	GO:0030018
GeneOntologyCellularComponent	sarcomere	DST SYNE2 PRKD1 CMYA5 MYZAP AHNAK2	5.71e-04	249	86	6	GO:0030017
GeneOntologyCellularComponent	I band	DST SYNE2 PRKD1 MYZAP AHNAK2	6.16e-04	166	86	5	GO:0031674
GeneOntologyCellularComponent	anchoring junction	AHI1 DST PTPRC SYNE2 KIRREL1 PRKD1 ATP1A1 MYZAP FYB1 FRMD4B AKAP12 ABCB1	6.33e-04	976	86	12	GO:0070161
GeneOntologyCellularComponent	myofibril	DST SYNE2 PRKD1 CMYA5 MYZAP AHNAK2	9.22e-04	273	86	6	GO:0030016
GeneOntologyCellularComponent	cell leading edge	ARAP3 DST MAP2 SYNJ2 SYNE2 PSD3 FRMD4B MEFV	1.05e-03	500	86	8	GO:0031252
GeneOntologyCellularComponent	contractile muscle fiber	DST SYNE2 PRKD1 CMYA5 MYZAP AHNAK2	1.26e-03	290	86	6	GO:0043292
GeneOntologyCellularComponent	autophagosome	PIK3C3 PRKD1 C9orf72 MEFV	1.48e-03	119	86	4	GO:0005776
GeneOntologyCellularComponent	cell projection membrane	NAPEPLD DHRS3 MAP2 SYNJ2 SYNE2 PSD3 KIRREL1	2.00e-03	431	86	7	GO:0031253
Domain	BROMODOMAIN_1	BRD8 BAZ2A BRD7 TAF1L	2.58e-05	37	87	4	PS00633
Domain	Bromodomain	BRD8 BAZ2A BRD7 TAF1L	2.87e-05	38	87	4	PF00439
Domain	BROMODOMAIN_2	BRD8 BAZ2A BRD7 TAF1L	3.90e-05	41	87	4	PS50014
Domain	BROMO	BRD8 BAZ2A BRD7 TAF1L	4.29e-05	42	87	4	SM00297
Domain	Bromodomain	BRD8 BAZ2A BRD7 TAF1L	4.29e-05	42	87	4	IPR001487
Domain	-	BRD8 BAZ2A BRD7 TAF1L	4.29e-05	42	87	4	1.20.920.10
Domain	Qua1	KHDRBS1 KHDRBS2	6.42e-05	3	87	2	PF16274
Domain	Qua1_dom	KHDRBS1 KHDRBS2	6.42e-05	3	87	2	IPR032571
Domain	Sam68-YY	KHDRBS1 KHDRBS2	6.42e-05	3	87	2	IPR032335
Domain	RGS-like	ARHGEF1 ARHGEF12	6.42e-05	3	87	2	PF09128
Domain	RGS-like_dom	ARHGEF1 ARHGEF12	6.42e-05	3	87	2	IPR015212
Domain	Sam68-YY	KHDRBS1 KHDRBS2	6.42e-05	3	87	2	PF16568
Domain	PIN_4	SWT1 DIS3	1.28e-04	4	87	2	PF13638
Domain	RII_binding_1	AKAP13 AKAP12	2.13e-04	5	87	2	PF10522
Domain	RII_binding_1	AKAP13 AKAP12	2.13e-04	5	87	2	IPR018459
Domain	PINc	SWT1 DIS3	3.18e-04	6	87	2	SM00670
Domain	PIN_dom	SWT1 DIS3	3.18e-04	6	87	2	IPR002716
Domain	Rho_GTPase_activation_prot	ARHGAP5 ARHGAP32 GAPVD1 ARAP3	7.60e-04	88	87	4	IPR008936
Domain	-	SWT1 DIS3	1.37e-03	12	87	2	3.40.50.1010
Domain	PIN_domain-like	SWT1 DIS3	1.88e-03	14	87	2	IPR029060
Domain	PH	ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 PRKD1	1.90e-03	278	87	6	SM00233
Domain	PH_DOMAIN	ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 PRKD1	1.93e-03	279	87	6	PS50003
Domain	PH_domain	ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 PRKD1	1.97e-03	280	87	6	IPR001849
Domain	-	ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 PRKD1 FRMD4B	2.32e-03	391	87	7	2.30.29.30
Domain	RhoGAP	ARHGAP5 ARHGAP32 ARAP3	3.03e-03	62	87	3	SM00324
Domain	RhoGAP	ARHGAP5 ARHGAP32 ARAP3	3.17e-03	63	87	3	PF00620
Domain	DH_1	ARHGEF1 ARHGEF12 AKAP13	3.17e-03	63	87	3	PS00741
Domain	RHOGAP	ARHGAP5 ARHGAP32 ARAP3	3.31e-03	64	87	3	PS50238
Domain	RhoGAP_dom	ARHGAP5 ARHGAP32 ARAP3	3.31e-03	64	87	3	IPR000198
Domain	-	ARHGAP5 ARHGAP32 ARAP3	3.31e-03	64	87	3	1.10.555.10
Domain	CH	DST SYNE2 ASPM	3.46e-03	65	87	3	SM00033
Domain	PH_dom-like	ARAP3 ARHGEF1 PSD3 ARHGEF12 AKAP13 PRKD1 FRMD4B	3.73e-03	426	87	7	IPR011993
Domain	RhoGEF	ARHGEF1 ARHGEF12 AKAP13	3.93e-03	68	87	3	SM00325
Domain	RhoGEF	ARHGEF1 ARHGEF12 AKAP13	4.27e-03	70	87	3	PF00621
Domain	CH	DST SYNE2 ASPM	4.27e-03	70	87	3	PF00307
Domain	DH_2	ARHGEF1 ARHGEF12 AKAP13	4.27e-03	70	87	3	PS50010
Domain	DH-domain	ARHGEF1 ARHGEF12 AKAP13	4.44e-03	71	87	3	IPR000219
Domain	-	ARHGEF1 ARHGEF12 AKAP13	4.44e-03	71	87	3	1.20.900.10
Domain	-	DST SYNE2 ASPM	4.44e-03	71	87	3	1.10.418.10
Domain	CH	DST SYNE2 ASPM	4.80e-03	73	87	3	PS50021
Domain	Actinin_actin-bd_CS	DST SYNE2	5.09e-03	23	87	2	IPR001589
Domain	Spectrin	DST SYNE2	5.09e-03	23	87	2	PF00435
Domain	ACTININ_2	DST SYNE2	5.09e-03	23	87	2	PS00020
Domain	ACTININ_1	DST SYNE2	5.09e-03	23	87	2	PS00019
Domain	CH-domain	DST SYNE2 ASPM	5.18e-03	75	87	3	IPR001715
Domain	Bromodomain_CS	BAZ2A TAF1L	6.48e-03	26	87	2	IPR018359
Domain	FHA	CHFR MKI67	7.49e-03	28	87	2	SM00240
Domain	Spectrin_repeat	DST SYNE2	8.03e-03	29	87	2	IPR002017
Domain	FHA_DOMAIN	CHFR MKI67	9.14e-03	31	87	2	PS50006
Domain	FHA	CHFR MKI67	9.14e-03	31	87	2	PF00498
Pathway	PID_RHOA_REG_PATHWAY	ARHGAP5 ARAP3 ARHGEF1 ARHGEF12 AKAP13	1.41e-06	46	60	5	M68
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARHGEF1 ARHGEF12 AKAP13	1.08e-05	69	60	5	MM15596
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARHGEF1 ARHGEF12 AKAP13	1.15e-05	70	60	5	M41806
Pathway	REACTOME_RHOC_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARHGEF1 ARHGEF12 AKAP13	1.15e-05	70	60	5	MM15597
Pathway	REACTOME_RHOC_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARHGEF1 ARHGEF12 AKAP13	1.52e-05	74	60	5	M41807
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARAP3 ARHGEF1 ARHGEF12 AKAP13	3.01e-05	142	60	6	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARAP3 ARHGEF1 ARHGEF12 AKAP13	3.94e-05	149	60	6	M41805
Pathway	REACTOME_CELL_CELL_COMMUNICATION	DST KIRREL1 SIRPB2 FYB1 ZEB2	5.36e-05	96	60	5	MM14592
Pathway	REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING	KHDRBS1 KHDRBS2	1.77e-04	5	60	2	M27731
Pathway	REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING	KHDRBS1 KHDRBS2	1.77e-04	5	60	2	MM15481
Pathway	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	PTPRC PHF11 ITPR2	4.74e-04	36	60	3	M1315
Pathway	REACTOME_RHO_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARAP3 DST ARHGEF1 ARHGEF12 AKAP13 AKAP12	5.13e-04	439	60	8	MM15595
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	ARHGEF1 AKAP13 PRKD1 AKAP12	5.77e-04	90	60	4	MM15882
Pathway	WP_G_PROTEIN_SIGNALING	ARHGEF1 AKAP13 PRKD1 AKAP12	6.01e-04	91	60	4	M39426
Pathway	REACTOME_RHO_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARAP3 DST ARHGEF1 ARHGEF12 AKAP13 AKAP12	6.04e-04	450	60	8	M27078
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY	ARHGEF1 ARHGEF12	6.29e-04	9	60	2	M47546
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARHGAP5 ARHGAP32 ARAP3 ARHGEF12	6.80e-04	94	60	4	MM15598
Pathway	REACTOME_RHOF_GTPASE_CYCLE	ARHGAP5 ARHGAP32 AKAP12	6.96e-04	41	60	3	MM15630
Pathway	REACTOME_RHOF_GTPASE_CYCLE	ARHGAP5 ARHGAP32 AKAP12	7.48e-04	42	60	3	M41821
Pathway	BIOCARTA_MYOSIN_PATHWAY	ARHGAP5 ARHGEF1	9.56e-04	11	60	2	M7014
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GAPVD1 DST TCOF1 BAZ2A TUT7 SYNE2 MKI67 YTHDC2 NUP188 ATP1A1 ADNP DIS3 FKBP4	1.22e-08	653	89	13	22586326
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	FBXO40 DST PCDH11X MKI67 YTHDC2 CEP295 AKAP12 SLC45A4	1.59e-07	233	89	8	37704626
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GAPVD1 TCOF1 HSPA4L TUT7 BRD7 MKI67 YTHDC2 NUP188 ADNP ITPR2	1.98e-07	440	89	10	34244565
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	KHDRBS1 TCOF1 BAZ2A NFIC MKI67 NUP188 ADNP DIS3 ITPR2	2.41e-07	341	89	9	32971831
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STK3 ARHGAP32 GAPVD1 DST MAP2 SYNJ2 PIK3C3 ARHGEF1 SYNE2 PSD3 AKAP13 TSC22D4 AHNAK2	2.98e-07	861	89	13	36931259
Pubmed	Human transcription factor protein interaction networks.	ARHGAP32 TAF8 BRD8 DST KHDRBS1 HSPA4L NFIC SYNE2 BRD7 MKI67 ZBTB40 ATP1A1 ADNP TAF1L ZEB2 FKBP4	6.31e-07	1429	89	16	35140242
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GAPVD1 DST KHDRBS1 TCOF1 SYNE2 MKI67 YTHDC2 NUP188 ATP1A1 ADNP FKBP4 ABCB1 ITPR2	2.06e-06	1024	89	13	24711643
Pubmed	CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.	ARAP3 SYNJ2 ARHGEF1	2.63e-06	11	89	3	15090612
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ARHGAP5 GAPVD1 BRD8 AHI1 PTPRC ARHGEF1 TUT7 ZBTB40 CEP295 NUP188 DIS3 GPATCH2L AKAP12	3.83e-06	1084	89	13	11544199
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAPVD1 DST TCOF1 BAZ2A MKI67 YTHDC2 ATP1A1 ADNP DIS3 FKBP4 AKAP12 AHNAK2	4.67e-06	934	89	12	33916271
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 GAPVD1 KHDRBS1 MKI67 KIRREL1 YTHDC2 AHNAK2	5.30e-06	263	89	7	34702444
Pubmed	Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.	ARHGEF1 ARHGEF12	6.48e-06	2	89	2	14712228
Pubmed	Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.	AKAP13 PRKD1	6.48e-06	2	89	2	26192751
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE2 EXOC6B PSD3 DIS3 FRMD4B	6.71e-06	102	89	5	10231032
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ARHGAP32 GAPVD1 DST TCOF1 HSPA4L PSD3 ARHGEF12 YTHDC2 ATP1A1 AKAP12	1.37e-05	708	89	10	39231216
Pubmed	Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias.	MKI67 ASPM ODF2	1.79e-05	20	89	3	34237032
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CCDC170 ARHGAP5 GAPVD1 DST DHRS3 AKAP13 CEP295 NUP188 BANK1 ITPR2	1.91e-05	736	89	10	29676528
Pubmed	Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.	ARHGEF1 ARHGEF12	1.94e-05	3	89	2	15143072
Pubmed	Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling.	ATP1A1 ABCB1	1.94e-05	3	89	2	26158764
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MKI67 MUC16	1.94e-05	3	89	2	27163153
Pubmed	Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).	ARHGEF1 ARHGEF12	1.94e-05	3	89	2	21454492
Pubmed	Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.	PTPRC ABCB1	1.94e-05	3	89	2	21599592
Pubmed	Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.	CYP1A2 ABCB1	1.94e-05	3	89	2	16800822
Pubmed	B plexins activate Rho through PDZ-RhoGEF.	ARHGEF1 ARHGEF12	1.94e-05	3	89	2	12372594
Pubmed	SAM68-Specific Splicing Is Required for Proper Selection of Alternative 3' UTR Isoforms in the Nervous System.	KHDRBS1 KHDRBS2	1.94e-05	3	89	2	31805436
Pubmed	Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism?	KHDRBS1 KHDRBS2	1.94e-05	3	89	2	19254361
Pubmed	Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68.	KHDRBS1 KHDRBS2	1.94e-05	3	89	2	19091369
Pubmed	Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.	STK3 PTPRC MKI67	2.41e-05	22	89	3	23454691
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MAP2 TCOF1 HSPA4L BAZ2A SYNE2 ASPM PSD3 KIRREL1 AKAP13 TSC22D4 C9orf72 FKBP4 AKAP12 ITPR2	2.43e-05	1487	89	14	33957083
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DST KHDRBS1 HSPA4L BAZ2A TUT7 SYNE2 BRD7 YTHDC2 NUP188 ATP1A1 C9orf72 FKBP4 AHNAK2 ITPR2	2.60e-05	1496	89	14	32877691
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 BRD8 PTPRC TCOF1 BAZ2A NFIC MKI67 ZBTB40 YTHDC2 ODF2	2.94e-05	774	89	10	15302935
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	TCOF1 BAZ2A MKI67 ADNP	3.61e-05	72	89	4	31248990
Pubmed	TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.	STK3 TNFAIP8	3.87e-05	4	89	2	28152516
Pubmed	Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation.	ARHGEF1 AKAP13	3.87e-05	4	89	2	12270917
Pubmed	The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.	KHDRBS1 KHDRBS2	3.87e-05	4	89	2	15471878
Pubmed	SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1.	KHDRBS1 KHDRBS2	3.87e-05	4	89	2	22196734
Pubmed	Ahi1, whose human ortholog is mutated in Joubert syndrome, is required for Rab8a localization, ciliogenesis and vesicle trafficking.	AHI1 ODF2	3.87e-05	4	89	2	19625297
Pubmed	PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk.	PIK3C3 PRKD1	3.87e-05	4	89	2	22095288
Pubmed	Embryonic expression of pericentrin suggests universal roles in ciliogenesis.	MAP2 MKI67	3.87e-05	4	89	2	16534625
Pubmed	Investigating the Effect of Demographics, Clinical Characteristics, and Polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on Clopidogrel Resistance.	CYP1A2 ABCB1	3.87e-05	4	89	2	30422888
Pubmed	RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.	STK3 KHDRBS1 HSPA4L YTHDC2 NUP188	4.06e-05	148	89	5	35676246
Pubmed	The C9ORF72 repeat expansion alters neurodevelopment.	MKI67 C9orf72	6.44e-05	5	89	2	37590144
Pubmed	Characterization of Sam68-like mammalian proteins SLM-1 and SLM-2: SLM-1 is a Src substrate during mitosis.	KHDRBS1 KHDRBS2	6.44e-05	5	89	2	10077576
Pubmed	Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.	PTPRC MKI67	6.44e-05	5	89	2	9990064
Pubmed	Neuronal cell type-specific alternative splicing is regulated by the KH domain protein SLM1.	KHDRBS1 KHDRBS2	6.44e-05	5	89	2	24469635
Pubmed	BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor.	BANK1 ITPR2	6.44e-05	5	89	2	11782428
Pubmed	Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation.	PIK3C3 ATP1A1	6.44e-05	5	89	2	29321306
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GAPVD1 DST SYNJ2 NUP188 ADNP DIS3 FRMD4B GPATCH2L	6.52e-05	529	89	8	14621295
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGAP5 ARHGAP32 GAPVD1 SYNJ2 TUT7 KIAA0319L CEP295 ATP1A1 ODF2 FKBP4	6.62e-05	853	89	10	28718761
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ARHGAP5 ARHGAP32 DST KHDRBS1 MAP2 HSPA4L ARHGEF1 PSD3 ARHGEF12 YTHDC2 ATP1A1 TSC22D4 ITPR2	7.03e-05	1431	89	13	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	DST KHDRBS1 HSPA4L SYNE2 KHDRBS2 ASPM CEP295 TNFAIP8 ATP1A1 ODF2 USPL1 ZEB2 ABCB1	7.59e-05	1442	89	13	35575683
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	DST SYNJ2 HSPA4L TUT7 YTHDC2 ATP1A1 DIS3 FKBP4	8.23e-05	547	89	8	37267103
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	DST TCOF1 BAZ2A NFIC ARHGEF1 BRD7 MKI67	9.03e-05	410	89	7	26949251
Pubmed	BMPR2 is required for postimplantation uterine function and pregnancy maintenance.	PTPRC MKI67 FKBP4	9.15e-05	34	89	3	23676498
Pubmed	Dynamic expression of the RNA-binding protein Sam68 during mouse pre-implantation development.	KHDRBS1 KHDRBS2	9.65e-05	6	89	2	18321792
Pubmed	AKAP-Lbc nucleates a protein kinase D activation scaffold.	AKAP13 PRKD1	9.65e-05	6	89	2	15383279
Pubmed	The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.	PTPRC ZEB2	9.65e-05	6	89	2	21355089
Pubmed	Loss of the neurodevelopmental Joubert syndrome causing protein, Ahi1, causes motor and muscle development delays independent of central nervous system involvement.	AHI1 ATP1A1	9.65e-05	6	89	2	30695685
Pubmed	Potent activation of RhoA by Galpha q and Gq-coupled receptors.	ARHGEF1 ARHGEF12	9.65e-05	6	89	2	12016230
Pubmed	Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.	CYP1A2 ABCB1	9.65e-05	6	89	2	17635176
Pubmed	A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis.	ARHGEF1 ARHGEF12	9.65e-05	6	89	2	20300064
Pubmed	Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1.	KHDRBS1 KHDRBS2	9.65e-05	6	89	2	12529443
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	STK3 SYNJ2 MKI67 AKAP13 YTHDC2 ATP1A1 AKAP12 AHNAK2 TAF1D	1.01e-04	724	89	9	36232890
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ARHGAP32 KHDRBS1 NFIC KIAA0319L KIRREL1	1.03e-04	180	89	5	35198878
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ARHGAP5 ARHGAP32 DST PSD3 KIRREL1 ATP1A1 AKAP12	1.06e-04	421	89	7	36976175
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ARHGAP32 KIAA0319L PCDH11X PSD3 KIRREL1 ATP1A1 FYB1 ABCB1	1.08e-04	569	89	8	30639242
Pubmed	Bioinformatics and cellular signaling.	KHDRBS1 ARHGEF1 BRD7 AKAP13 BANK1	1.08e-04	182	89	5	15102471
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAPVD1 SYNJ2 TUT7 KIRREL1 AKAP13 CEP295 POLD3 FRMD4B ITPR2	1.11e-04	733	89	9	34672954
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	STK3 GAPVD1 DST HSPA4L PRKD1 NUP188 ADNP TAF1L GPATCH2L ITPR2	1.13e-04	910	89	10	36736316
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	DST TCOF1 PIK3C3 NFIC ARHGEF1 SYNE2 MKI67 AKAP13 NUP188 ATP1A1 FKBP4 AKAP12	1.15e-04	1297	89	12	33545068
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DST ARHGEF1 SYNE2 ARHGEF12 PRKD1	1.23e-04	187	89	5	26460568
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	ARHGEF1 ARHGEF12 AKAP13	1.28e-04	38	89	3	19911011
Pubmed	Coordinated lymphangiogenesis is critical in lymph node development and maturation.	PTPRC MKI67	1.35e-04	7	89	2	27623309
Pubmed	Sam68 promotes self-renewal and glycolytic metabolism in mouse neural progenitor cells by modulating Aldh1a3 pre-mRNA 3'-end processing.	KHDRBS1 MKI67	1.35e-04	7	89	2	27845622
Pubmed	Osterix is dispensable for the development of the mouse olfactory bulb.	MAP2 MKI67	1.35e-04	7	89	2	27449610
Pubmed	Analysis of extracellular signal-regulated kinase 2 function in neural stem/progenitor cells via nervous system-specific gene disruption.	MAP2 MKI67	1.35e-04	7	89	2	18818436
Pubmed	Mst1 and mst2 are essential regulators of trophoblast differentiation and placenta morphogenesis.	STK3 MKI67	1.35e-04	7	89	2	24595170
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TCOF1 BAZ2A MKI67 ADNP	1.46e-04	103	89	4	32744500
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ARAP3 DST BAZ2A ARHGEF1 TUT7 MKI67 ASPM AKAP13 POLD3 ADNP DIS3 AHNAK2	1.71e-04	1353	89	12	29467282
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GAPVD1 DST TCOF1 KIAA0319L MKI67 MUC16 KIRREL1 ATP1A1 AKAP12	1.71e-04	777	89	9	35844135
Pubmed	NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation.	PTPRC NFIC MKI67	1.73e-04	42	89	3	37353485
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 DST TCOF1 SYNE2 BRD7 ARHGEF12 PRKD1 ADNP ZEB2 AKAP12	1.78e-04	963	89	10	28671696
Pubmed	Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.	CYP1A2 ABCB1	1.79e-04	8	89	2	17259654
Pubmed	The zinc finger transcription factor RP58 negatively regulates Rnd2 for the control of neuronal migration during cerebral cortical development.	MAP2 MKI67	1.79e-04	8	89	2	24084125
Pubmed	Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network.	PTPRC MKI67	1.79e-04	8	89	2	19995948
Pubmed	Intra-aortic clusters undergo endothelial to hematopoietic phenotypic transition during early embryogenesis.	PTPRC MKI67	1.79e-04	8	89	2	22558218
Pubmed	Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.	PTPRC MKI67	1.79e-04	8	89	2	29946151
Pubmed	The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells.	MAP2 MKI67	1.79e-04	8	89	2	10627606
Pubmed	A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.	CYP1A2 ABCB1	1.79e-04	8	89	2	20147896
Pubmed	TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone.	MAP2 MKI67	1.79e-04	8	89	2	25044744
Pubmed	ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.	CYP1A2 ABCB1	1.79e-04	8	89	2	19593168
Pubmed	ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules.	MKI67 ASPM	1.79e-04	8	89	2	27562601
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	BRD7 ZEB2 FKBP4 ZFP62	1.82e-04	109	89	4	33554859
Pubmed	Dominant and redundant functions of TFIID involved in the regulation of hepatic genes.	CYP1A2 TAF8 TAF1L	1.86e-04	43	89	3	18722179
Pubmed	A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum.	BRD8 KHDRBS1 KHDRBS2	1.99e-04	44	89	3	32492419
Pubmed	A protein interaction landscape of breast cancer.	GAPVD1 DST TCOF1 HSPA4L BRD7 MKI67 NUP188 FKBP4	2.25e-04	634	89	8	34591612
Pubmed	ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.	CYP1A2 ABCB1	2.30e-04	9	89	2	17178267
Pubmed	A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.	CCDC170 AKAP12	2.30e-04	9	89	2	21540461
Pubmed	Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome.	AHI1 MKI67	2.30e-04	9	89	2	21623382
Pubmed	Consequence of the loss of Sox2 in the developing brain of the mouse.	MAP2 MKI67	2.30e-04	9	89	2	18638478
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 AKAP13 CMYA5 AKAP12	2.79e-06	29	62	4	396
GeneFamily	Signal transduction and activation of RNA metabolism family	KHDRBS1 KHDRBS2	3.46e-05	3	62	2	1275
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP ZEB2	1.18e-03	15	62	2	529
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF1 ARHGEF12 AKAP13	1.51e-03	66	62	3	722
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	STK3 ARHGAP5 TAF8 BRD8 KHDRBS1 MAP2 TCOF1 PIK3C3 NFIC POLD3 FRMD4B ZEB2 AKAP12 TAF1D	3.00e-07	776	88	14	M1107
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	STK3 ARHGAP5 TAF8 BRD8 KHDRBS1 MAP2 TCOF1 PIK3C3 NFIC POLD3 FRMD4B ZEB2 AKAP12 TAF1D	3.95e-07	794	88	14	MM982
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	GAPVD1 BRD8 DST PIK3C3 MKI67 PSD3 TNFAIP8 POLD3 ADNP	7.74e-07	300	88	9	M8702
Coexpression	BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS	DST NFIC SYNE2 MKI67 ASPM	3.88e-06	70	88	5	M40002
Coexpression	CAMP_UP.V1_DN	ARHGAP5 DST PTPRC CHST15 MAP2 ARHGEF12 AKAP12	4.94e-06	199	88	7	M2719
Coexpression	GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN	ARHGAP32 CHST15 ARHGEF12 DDI1 ZNF804A FKBP4 AKAP12	5.10e-06	200	88	7	M9335
Coexpression	ZHONG_PFC_C4_PTGDS_POS_OPC	ARHGAP5 KIAA0319L PCDH11X TSC22D4 FRMD4B ITPR2	1.04e-05	147	88	6	M39099
Coexpression	ONKEN_UVEAL_MELANOMA_UP	STK3 AHI1 PTPRC PIK3C3 SYNE2 PHF11 AKAP13 TNFAIP8 FRMD4B ZEB2 AHNAK2 ITPR2	1.30e-05	790	88	12	M12490
Coexpression	JIANG_MELANOMA_TRM7_CD8	PTPRC ARHGEF1 TNFAIP8 TSC22D4 FYB1	1.34e-05	90	88	5	M48971
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	ARHGAP5 DHRS3 SYNJ2 NFIC SYNE2 PHF11 TNFAIP8 ATP1A1 ZEB2 WDPCP GPATCH2L SLC45A4	1.61e-05	807	88	12	M16651
Coexpression	AIZARANI_LIVER_C30_HEPATOCYTES_4	TAF8 AHI1 DST HSPA4L PIK3C3 TUT7 SLC14A2 DIS3 ITPR2	1.92e-05	446	88	9	M39129
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	STK3 AHI1 DST KHDRBS1 DHRS3 HSPA4L BAZ2A ZBTB40 USPL1 ZEB2 FKBP4 AHNAK2	1.93e-05	822	88	12	M6782
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	STK3 GAPVD1 DST SYNJ2 PIK3C3 SYNE2 PSD3 AKAP13 TNFAIP8 ADNP ZNF804A ZEB2	2.87e-05	856	88	12	M4500
Coexpression	ZHENG_BOUND_BY_FOXP3	ARHGAP5 TAF8 PTPRC SYNE2 EXOC6B AKAP13 FYB1 FRMD4B ITPR2	4.54e-05	498	88	9	M1741
Coexpression	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	DST PTPRC CHST15 NFIC PHF11 ZNF804A ZEB2	4.68e-05	282	88	7	M7623
Coexpression	ZHENG_BOUND_BY_FOXP3	ARHGAP5 TAF8 PTPRC SYNE2 EXOC6B AKAP13 FYB1 FRMD4B ITPR2	5.21e-05	507	88	9	MM1030
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	ARHGAP32 DHRS3 ARHGEF1 ZBTB40 ATP1A1 SLC4A5	5.43e-05	197	88	6	M8611
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_19_PRECICTIVE_ICB_RESPONSE	HSPA4L AKAP13 DTX3L FYB1 ZNF804A AHNAK2	5.43e-05	197	88	6	MM17080
Coexpression	GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN	PIK3C3 YTHDC2 TAF1L SLC4A5 ZEB2 SLC45A4	5.58e-05	198	88	6	M6224
Coexpression	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	TUT7 CHFR ARHGEF12 C9orf72 FYB1 MEFV	5.74e-05	199	88	6	M5726
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN	CYP1A2 SYNJ2 PIK3C3 TUT7 TNFAIP8 TAF1D	5.90e-05	200	88	6	M8842
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	DST PSD3 ARHGEF12 KIRREL1 CMYA5 ZNF804A	8.14e-05	212	88	6	M39221
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	DST PTPRC DHRS3 CHST15 TUT7 SYNE2 ARHGEF12 AKAP13 DTX3L TNFAIP8 ATP1A1 FYB1 ABCB1 ITPR2	8.61e-05	1276	88	14	M39173
Coexpression	GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	AHI1 DST EXOC6B SLC4A5 ITPR2	1.31e-04	145	88	5	M359
Coexpression	CUI_TCF21_TARGETS_2_DN	STK3 ARHGAP5 DST PTPRC TUT7 PSD3 KIRREL1 TNFAIP8 MYZAP ZEB2 ABCB1	1.34e-04	854	88	11	M1533
Coexpression	BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS	NFIC SYNE2 MKI67 ASPM	1.47e-04	79	88	4	M40003
Coexpression	CUI_TCF21_TARGETS_2_DN	STK3 ARHGAP5 DST PTPRC TUT7 PSD3 KIRREL1 TNFAIP8 MYZAP ZEB2 ABCB1	1.88e-04	888	88	11	MM1018
Coexpression	LEIN_CEREBELLUM_MARKERS	ARHGAP5 DHRS3 SYNE2 CMYA5	1.95e-04	85	88	4	MM720
Coexpression	LEIN_CEREBELLUM_MARKERS	ARHGAP5 DHRS3 SYNE2 CMYA5	1.95e-04	85	88	4	M1723
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	STK3 DST ZEB2 AKAP12	2.04e-04	86	88	4	M39247
Coexpression	GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP	ARHGAP5 DST SYNE2 ARHGEF12 FRMD4B	2.07e-04	160	88	5	M6863
Coexpression	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	MKI67 ASPM PSD3 AHNAK2	2.33e-04	89	88	4	M2761
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	STK3 AHI1 PRKD1 ATP1A1 ITPR2	2.67e-04	169	88	5	M39230
Coexpression	BENPORATH_CYCLING_GENES	BRD8 AHI1 NFIC BRD7 MKI67 AKAP13 POLD3 ODF2 DIS3	3.28e-04	648	88	9	M8156
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	ARHGAP5 AHI1 HSPA4L TUT7 SYNE2 MKI67 ASPM FYB1 ITPR2	3.59e-04	656	88	9	M18979
Coexpression	LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3	ARHGAP5 AHI1 SYNE2 AKAP12 TAF1D	3.66e-04	181	88	5	M39225
Coexpression	JIANG_MELANOMA_TRM9_CD8	PTPRC KHDRBS1 ARHGEF1 SYNE2 AKAP13 ATP1A1 TSC22D4 FYB1	3.93e-04	526	88	8	M48973
Coexpression	AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4	DST SYNJ2 SYNE2 ATP1A1 ABCB1	3.95e-04	184	88	5	M39135
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN	SWT1 HSPA4L PHF11 DTX3L USPL1	4.46e-04	189	88	5	M4261
Coexpression	PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP	STK3 PTPRC CHST15 SYNJ2 ZEB2 AKAP12	4.50e-04	291	88	6	M41002
Coexpression	HELLER_HDAC_TARGETS_DN	PTPRC CHST15 NFIC PHF11 ZEB2 FKBP4	4.66e-04	293	88	6	M6890
Coexpression	SHEPARD_CRASH_AND_BURN_MUTANT_DN	KHDRBS1 MKI67 ASPM CEP295 ATP1A1	4.68e-04	191	88	5	M2148
Coexpression	LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES	PTPRC AKAP12	4.93e-04	10	88	2	M39249
Coexpression	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	CYP1A2 SYNE2 YTHDC2 PRKD1 POLD3	5.39e-04	197	88	5	M8983
Coexpression	GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN	DST PHF11 ZBTB40 SLC14A2 SLC4A5	5.39e-04	197	88	5	M5786
Coexpression	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	AHI1 MKI67 ASPM MUC16 ZEB2	5.51e-04	198	88	5	M8041
Coexpression	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN	AHI1 TCOF1 FYB1 AKAP12 ITPR2	5.51e-04	198	88	5	M4554
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	PTPRC TUT7 ASPM ARHGEF12 POLD3	5.51e-04	198	88	5	M4424
Coexpression	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP	FCRL1 PTPRC DTX3L FYB1 FRMD4B	5.64e-04	199	88	5	M6420
Coexpression	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP	FCRL1 PTPRC TNFAIP8 MEFV ABCB1	5.64e-04	199	88	5	M8964
Coexpression	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	SWT1 EXOC6B AKAP13 USPL1 ZEB2	5.64e-04	199	88	5	M3517
Coexpression	HALLMARK_MITOTIC_SPINDLE	ARHGAP5 ARAP3 DST ARHGEF12 AKAP13	5.64e-04	199	88	5	M5893
Coexpression	GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP	ARHGAP32 DHRS3 ATP1A1 SLC4A5 WDPCP	5.64e-04	199	88	5	M8609
Coexpression	GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	STK3 DST CHST15 CHFR ZNF804A	5.64e-04	199	88	5	M5446
Coexpression	GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	CCDC170 STK3 ARAP3 PRKD1 MEFV	5.64e-04	199	88	5	M4474
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_UP	STK3 DST PSD3 FRMD4B FKBP4	5.77e-04	200	88	5	M9406
Coexpression	GSE14308_INDUCED_VS_NATURAL_TREG_DN	TAF8 SYNJ2 PRODH SLC45A4 ITPR2	5.77e-04	200	88	5	M3399
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	BRD8 CHFR MKI67 FRMD4B AKAP12	5.77e-04	200	88	5	M8959
Coexpression	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	CHST15 BAZ2A TUT7 PSD3 FYB1	5.77e-04	200	88	5	M302
Coexpression	GSE27786_CD4_TCELL_VS_NKCELL_DN	STK3 PTPRC DHRS3 NFIC NUP188	5.77e-04	200	88	5	M4823
Coexpression	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	TAF8 ASPM TNFAIP8 AKAP12 ITPR2	5.77e-04	200	88	5	M3428
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	STK3 ARHGAP32 AHI1 MKI67 ITPR2	5.77e-04	200	88	5	M3446
Coexpression	GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	DHRS3 HSPA4L CEP295 POLD3 ODF2	5.77e-04	200	88	5	M8614
Coexpression	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN	FAM50B CYP1A2 NUP188 FRMD4B MEFV	5.77e-04	200	88	5	M3777
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	SYNJ2 YTHDC2 SLC14A2 SLC45A4 VSTM1	5.77e-04	200	88	5	M6237
Coexpression	GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	FCRL1 CHST15 EXOC6B ZBTB40 SLC45A4	5.77e-04	200	88	5	M7417
Coexpression	ONGUSAHA_BRCA1_TARGETS_DN	ARHGAP5 ZFP62	6.01e-04	11	88	2	MM881
Coexpression	ONGUSAHA_BRCA1_TARGETS_DN	ARHGAP5 ZFP62	6.01e-04	11	88	2	M2068
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	STK3 PTPRC BAZ2A PCDH11X PSD3 USPL1 DIS3 ZEB2 AKAP12	6.03e-04	705	88	9	M1410
Coexpression	HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS	NFIC ASPM PRKD1 TNFAIP8 POLD3 ATP1A1 TSC22D4	6.34e-04	432	88	7	MM419
CoexpressionAtlas	Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3	ARHGAP32 FCRL1 DST SYNE2 PSD3 ARHGEF12 SIRPB2 C9orf72 FRMD4B ZEB2 BANK1	8.68e-07	403	88	11	GSM605853_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	GAPVD1 BRD8 SYNE2 PCDH11X ASPM CEP295 FRMD4B ZEB2	1.98e-05	277	88	8	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ARHGAP5 AHI1 NAPEPLD MAP2 TCOF1 SWT1 HSPA4L SYNE2 PHF11 BRD7 MKI67 ASPM CEP295 ODF2 ADNP SLC4A5 ZFP62 TAF1D	2.50e-05	1459	88	18	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	ARHGAP5 TAF8 NAPEPLD MAP2 TCOF1 SWT1 SYNE2 BRD7 MKI67 ASPM CEP295 TNFAIP8 ODF2 ADNP ZFP62 TAF1D	5.01e-05	1252	88	16	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	CCDC170 ARHGAP5 MAP2 TCOF1 SYNE2 BRD7 CHFR PCDH11X MKI67 ARHGEF12 CEP295 TNFAIP8 ODF2 ADNP	5.31e-05	989	88	14	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	GAPVD1 BRD8 SYNE2 PCDH11X ASPM CEP295 FRMD4B ZEB2	5.88e-05	323	88	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_100	PTPRC FYB1 BANK1	6.35e-05	19	88	3	gudmap_developingKidney_e15.5_Endothelial cells_100_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	GAPVD1 BRD8 CHST15 SYNE2 PCDH11X ASPM YTHDC2 CEP295 PRKD1 FRMD4B ZEB2 ZFP62	1.17e-04	804	88	12	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	GAPVD1 BRD8 CHST15 SYNE2 PCDH11X ASPM YTHDC2 CEP295 ZNF804A FRMD4B ZEB2 ZFP62	1.33e-04	815	88	12	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	GAPVD1 SYNE2 PCDH11X ASPM CEP295 FRMD4B ZFP62	1.47e-04	275	88	7	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000	ARHGAP32 BRD8 AHI1 PTPRC KHDRBS1 ARHGEF12 KIRREL1 DTX3L FYB1 ZEB2 BANK1 AKAP12	1.68e-04	836	88	12	gudmap_developingKidney_e15.5_Podocyte cells_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	GAPVD1 SYNE2 PCDH11X ASPM CEP295 FRMD4B ZEB2	1.79e-04	284	88	7	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3	FCRL1 CHST15 MKI67 ASPM PSD3 ZEB2 BANK1 AKAP12	1.90e-04	383	88	8	GSM399448_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	ARHGAP5 AHI1 NAPEPLD MAP2 SWT1 HSPA4L SYNE2 MKI67 ASPM CEP295 ODF2 ZNF804A FRMD4B WDPCP ABCB1 TAF1D	2.07e-04	1414	88	16	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	SYNE2 PCDH11X ASPM CEP295 ZNF804A FRMD4B ZEB2 ZFP62	3.38e-04	417	88	8	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	MAP2 SYNE2 PCDH11X PSD3 MUC16 PRKD1 TNFAIP8 C9orf72 FRMD4B ZEB2 ITPR2	3.85e-04	783	88	11	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	HSPA4L YTHDC2 C9orf72 ZFP62 ABCB1 ITPR2	3.91e-04	230	88	6	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	SYNE2 ASPM CEP295 FRMD4B ZEB2	4.02e-04	150	88	5	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	SWT1 HSPA4L BAZ2A PHF11 CHFR YTHDC2 MAP3K15 NUP188 POLD3 FYB1 DIS3	4.38e-04	795	88	11	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	CHST15 MAP2 NFIC PCDH11X PSD3 MUC16 PRKD1 TNFAIP8 C9orf72 FRMD4B ITPR2	4.47e-04	797	88	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	MAP2 NFIC PSD3 MUC16 TNFAIP8 FRMD4B	4.90e-04	240	88	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500	ZNF804A FRMD4B ZEB2 ZFP62	5.14e-04	89	88	4	gudmap_developingGonad_e11.5_ovary + mesonephros_k1_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	PCDH11X ASPM CEP295 FRMD4B ZEB2	5.56e-04	161	88	5	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	GAPVD1 SYNE2 ASPM CEP295 FRMD4B ZEB2	5.95e-04	249	88	6	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	CHST15 NFIC PSD3 YTHDC2 ZNF804A ZEB2 ABCB1	6.09e-04	348	88	7	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ARHGAP5 AHI1 NAPEPLD TCOF1 SWT1 SYNE2 BRD7 MKI67 ASPM CEP295 ODF2 ADNP ZFP62 TAF1D	6.33e-04	1257	88	14	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#2_top-relative-expression-ranked_200	PTPRC FYB1 BANK1	6.54e-04	41	88	3	gudmap_developingKidney_e15.5_Endothelial cells_200_k2
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	PTPRC CHST15 TUT7 SIRPB2 C9orf72 FYB1 ZEB2 MEFV	4.41e-09	189	89	8	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	PTPRC CHST15 MKI67 ASPM SIRPB2 FYB1 FRMD4B ZEB2	4.99e-09	192	89	8	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	PTPRC KHDRBS2 MKI67 ASPM SIRPB2 FYB1 FRMD4B ZEB2	5.20e-09	193	89	8	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 PTPRC CHST15 KHDRBS2 SIRPB2 FYB1 FRMD4B ZEB2	5.20e-09	193	89	8	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CCDC170 PTPRC SIRPB2 TNFAIP8 FYB1 ZNF804A ZEB2 ITPR2	6.11e-09	197	89	8	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGAP5 ARHGAP32 DST SYNE2 ARHGEF12 MUC16 ATP1A1 AHNAK2	6.88e-09	200	89	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCDC170 KHDRBS2 PSD3 FYB1 FRMD4B ZEB2 ITPR2	9.19e-08	185	89	7	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	GAPVD1 PTPRC NAPEPLD ZBTB40 USPL1 ZEB2 ITPR2	9.54e-08	186	89	7	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 SIRPB2 FYB1 ZNF804A ZEB2 MEFV	1.03e-07	188	89	7	4e27ada1bda88811b73376c8a6136cbfc83bfdb9
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	PTPRC CHST15 KHDRBS2 SIRPB2 FYB1 FRMD4B ZEB2	1.14e-07	191	89	7	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	BRD8 TCOF1 MKI67 ASPM GPATCH2L AHNAK2 TAF1D	1.18e-07	192	89	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	PTPRC CHST15 KHDRBS2 SIRPB2 FYB1 FRMD4B ZEB2	1.18e-07	192	89	7	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 KHDRBS2 SIRPB2 FYB1 FRMD4B ZEB2	1.23e-07	193	89	7	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	Monocytes\|World / lung cells shred on cell class, cell subclass, sample id	BRD8 PTPRC CHST15 FYB1 ZEB2 MEFV VSTM1	1.23e-07	193	89	7	d66d3927f8fbe1544b5cfa5ee91a7f4a0ef1e810
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	PTPRC CHST15 KHDRBS2 SIRPB2 FYB1 FRMD4B ZEB2	1.27e-07	194	89	7	f09675cd472200363c458952f00d2e41990800ee
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC KHDRBS2 SIRPB2 FYB1 ZNF804A FRMD4B ZEB2	1.32e-07	195	89	7	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 TUT7 SIRPB2 FYB1 ZEB2 MEFV	1.32e-07	195	89	7	1d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell	Fetal_29-31_weeks-Immune-monocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTPRC CHST15 SIRPB2 C9orf72 FYB1 ZEB2 MEFV	1.41e-07	197	89	7	48a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTPRC CHST15 SIRPB2 FYB1 ZNF804A ZEB2 MEFV	1.41e-07	197	89	7	8b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ARHGAP5 ARHGAP32 DST SYNE2 ARHGEF12 ATP1A1 AHNAK2	1.56e-07	200	89	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	PTPRC KHDRBS1 SYNE2 PHF11 BRD7 AKAP13 DTX3L	1.56e-07	200	89	7	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC CHST15 SIRPB2 C9orf72 ZNF804A ZEB2 MEFV	1.56e-07	200	89	7	8872d5fa101d413fb43b4231d476878678543035
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC CHST15 SIRPB2 C9orf72 ZNF804A ZEB2 MEFV	1.56e-07	200	89	7	fc061de0db2e8b5ca47f5e2a1e861018e7f1b582
ToppCell	normal_Lung-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	TCOF1 AKAP13 TNFAIP8 FYB1 FRMD4B ABCB1	1.04e-06	166	89	6	07b498eb341abec02a3ccaae320bdbb5cd6883c5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAPEPLD DHRS3 SYNJ2 ARHGEF12 KIRREL1 ZNF804A	1.83e-06	183	89	6	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAPEPLD DHRS3 SYNJ2 ARHGEF12 KIRREL1 ZNF804A	1.83e-06	183	89	6	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	GAPVD1 PTPRC NAPEPLD ZBTB40 USPL1 ZEB2	1.95e-06	185	89	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FCRL1 PTPRC KHDRBS2 TNFAIP8 BANK1 FKBP4	2.08e-06	187	89	6	57ea69f777420f0671b131c97bcce71d77e29286
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHST15 TUT7 AKAP13 C9orf72 ZEB2 MEFV	2.21e-06	189	89	6	55aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PTPRC CHST15 SIRPB2 FYB1 FRMD4B ZEB2	2.21e-06	189	89	6	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCDC170 KHDRBS2 PSD3 FRMD4B ZEB2 ITPR2	2.28e-06	190	89	6	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 PTPRC SIRPB2 FYB1 FRMD4B ZEB2	2.28e-06	190	89	6	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	FBXO40 DST EXOC6B PSD3 AKAP13 CMYA5	2.28e-06	190	89	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTPRC SYNE2 MKI67 ASPM TNFAIP8 FYB1	2.35e-06	191	89	6	912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCell	Monocytes-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	BRD8 PTPRC CHST15 FYB1 MEFV VSTM1	2.35e-06	191	89	6	ca0a5dc82cdef02e88fed937ca5784761896af33
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC KHDRBS2 SIRPB2 FYB1 ZNF804A ZEB2	2.35e-06	191	89	6	468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTPRC SYNE2 MKI67 ASPM TNFAIP8 FYB1	2.35e-06	191	89	6	77a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAF8 FCRL1 KHDRBS1 KHDRBS2 EXOC6B BANK1	2.49e-06	193	89	6	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRC CHST15 SIRPB2 FYB1 ZNF804A ZEB2	2.49e-06	193	89	6	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC CHST15 TUT7 C9orf72 FYB1 ZEB2	2.57e-06	194	89	6	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.57e-06	194	89	6	de9c7c602d886d0cd8bbd1d7e7744f84df951238
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.57e-06	194	89	6	49441ca0a8fa34cb847fecbb4b809dd01d879ebb
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC CHST15 TUT7 C9orf72 FYB1 ZEB2	2.57e-06	194	89	6	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	PTPRC CHST15 SIRPB2 FYB1 FRMD4B ZEB2	2.57e-06	194	89	6	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	medial-Hematologic-Nonclassical_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC CHST15 SIRPB2 FYB1 MEFV VSTM1	2.57e-06	194	89	6	ac203d388a3a3884e316dec0dcbd408e43c6ef6c
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.57e-06	194	89	6	16c6fcbd36d473b883fb5361caca86eb134767ab
ToppCell	medial-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC CHST15 SIRPB2 FYB1 MEFV VSTM1	2.57e-06	194	89	6	202e5070728191c46161fa7d931f00be1c7559d4
ToppCell	medial-Hematologic-Nonclassical_Monocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC CHST15 SIRPB2 FYB1 MEFV VSTM1	2.57e-06	194	89	6	002cd317732fc6b0d9a72fb46199f71db5a638a7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 DST DHRS3 CHST15 ZEB2 AKAP12	2.57e-06	194	89	6	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 DST DHRS3 CHST15 ZEB2 AKAP12	2.57e-06	194	89	6	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC SIRPB2 FYB1 ZNF804A ZEB2 MEFV	2.57e-06	194	89	6	badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.57e-06	194	89	6	dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	SIRPB2 C9orf72 FYB1 FRMD4B ZEB2 ITPR2	2.64e-06	195	89	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	distal-1-Hematologic-Nonclassical_Monocyte\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC CHST15 TUT7 FYB1 MEFV VSTM1	2.64e-06	195	89	6	e1a8171d1af53c2bbda758170c5053d3a3bb6ddd
ToppCell	distal-Hematologic-Classical_Monocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC CHST15 FYB1 ZEB2 MEFV VSTM1	2.64e-06	195	89	6	32c34741e35006b7238896fd04a497011297dd22
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	FBXO40 DST EXOC6B PSD3 AKAP13 CMYA5	2.64e-06	195	89	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 SIRPB2 FYB1 ZEB2 MEFV	2.64e-06	195	89	6	10ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	PTPRC CHST15 SIRPB2 FYB1 FRMD4B ZEB2	2.64e-06	195	89	6	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 PTPRC SIRPB2 FYB1 FRMD4B ZEB2	2.64e-06	195	89	6	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	cellseq-Immune-Immune_Myeloid-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC CHST15 FYB1 ZEB2 MEFV VSTM1	2.72e-06	196	89	6	5842d6fa0c066815d7d8c7e59b192bfc72960707
ToppCell	cellseq-Immune-Immune_Myeloid-iMON-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRC CHST15 FYB1 ZEB2 MEFV VSTM1	2.72e-06	196	89	6	8608be3c3e7fd776c5f2fae207cd0b801e138349
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	PTPRC CHST15 SIRPB2 FYB1 ZEB2 MEFV	2.81e-06	197	89	6	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	PTPRC SIRPB2 C9orf72 FYB1 ZNF804A ZEB2	2.81e-06	197	89	6	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.81e-06	197	89	6	c6e977adb1248957d31300312310e08238b64236
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC C9orf72 FYB1 ZEB2 MEFV VSTM1	2.81e-06	197	89	6	0c059476a8cdc6ac71a01d9c414295177f45f8de
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PTPRC CHST15 SIRPB2 FYB1 ZEB2 MEFV	2.89e-06	198	89	6	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC C9orf72 FYB1 ZEB2 MEFV VSTM1	2.89e-06	198	89	6	4b6767bd6fd4bd43eed18fd4a34c20923fa795da
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC C9orf72 FYB1 ZEB2 MEFV VSTM1	2.89e-06	198	89	6	18daf83309813f914b17bd226ea8a9269a26b107
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC C9orf72 FYB1 ZEB2 MEFV VSTM1	2.89e-06	198	89	6	72c7474e084d1334a09c0a3b0f3c3137038794c8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC SIRPB2 FYB1 ZNF804A ZEB2 MEFV	2.89e-06	198	89	6	623f9d64c9e800d2d7f623392bf2f22b563f0249
ToppCell	Immune-monocyte\|World / Lineage, Cell type, age group and donor	PTPRC CHST15 SIRPB2 C9orf72 FYB1 ZEB2	2.89e-06	198	89	6	d3622da252fd580f1dc5c7478a8e23df5ec083cf
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	KHDRBS1 SYNJ2 SYNE2 FYB1 AKAP12 TAF1D	2.97e-06	199	89	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.97e-06	199	89	6	e12cea071e46436835cc22fe7badcbe878a1305b
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC CHST15 C9orf72 FYB1 ZEB2 MEFV	2.97e-06	199	89	6	2ff5007b971c6fca9a9ef433e257739f0322a2a5
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CHST15 TCOF1 PSD3 SIRPB2 POLD3 SLC45A4	2.97e-06	199	89	6	bbb4798d6a24e756fea744a151ba67c1bafbac9a
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	DST CHST15 MAP2 PCDH11X PSD3 ARHGEF12	2.97e-06	199	89	6	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SYNE2 MKI67 ASPM TSC22D4 BANK1 AKAP12	2.97e-06	199	89	6	8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BRD8 DST KHDRBS1 NFIC SYNE2 BRD7	2.97e-06	199	89	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	DST CHST15 MAP2 PCDH11X PSD3 ARHGEF12	2.97e-06	199	89	6	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRC CHST15 TUT7 C9orf72 FYB1 ZEB2	3.06e-06	200	89	6	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FBXO40 PTPRC SIRPB2 ZEB2 MEFV VSTM1	3.06e-06	200	89	6	5ea3e74687893b8ca6cb915f0f14a14d4692775c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PTPRC SYNE2 BRD7 AKAP13 DTX3L ZEB2	3.06e-06	200	89	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	ARAP3 DST SYNJ2 SYNE2 ATP1A1 FRMD4B	3.06e-06	200	89	6	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Monocytic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC CHST15 C9orf72 ZEB2 MEFV VSTM1	3.06e-06	200	89	6	0855ebb10b925664aa5cf813d97e97683c46180d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC CHST15 SIRPB2 ZNF804A ZEB2 MEFV	3.06e-06	200	89	6	b4277b6faa69f20974696c7c422311f5c89e3663
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WDR87 TNFAIP8 SLC14A2 WDPCP ITPR2	9.79e-06	142	89	5	f720f13b339589fa924a42e89393e5db0b26300b
ToppCell	PND01-03-samps-Myeloid-Granulocyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PTPRC MAP3K15 TNFAIP8 FYB1 MEFV	1.24e-05	149	89	5	7bdb396de8a1ef27ab0c2aaf1452576f4b0b5561
ToppCell	PND01-03-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PTPRC MAP3K15 TNFAIP8 FYB1 MEFV	1.24e-05	149	89	5	50f53018e525b3d252caa8bed9e075b1bb1086dd
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122\|Adult / Lineage, Cell type, age group and donor	CCDC170 SIRPB2 FYB1 FRMD4B ZEB2	2.08e-05	166	89	5	be284e2e596390f05305c7bcfc316f87b963fc0b
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	FCRL1 PTPRC TNFAIP8 ZNF804A BANK1	2.20e-05	168	89	5	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KHDRBS2 SIRPB2 ZNF804A ZEB2 MEFV	2.20e-05	168	89	5	61a5435b27b01ff1a509ea463a6af220c5d2c9b3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KHDRBS2 SIRPB2 ZNF804A ZEB2 MEFV	2.20e-05	168	89	5	26fce414439ccd204e3acb41f2b4f75072df5a26
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC MAP2 CMYA5 FYB1 ITPR2	2.33e-05	170	89	5	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo\|Lung / Manually curated celltypes from each tissue	PTPRC SYNE2 MKI67 ASPM ABCB1	2.40e-05	171	89	5	dfd4a15ab68ef5a9a1954b1b1540ae04017885a6
ToppCell	COVID-19-kidney-Bcells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FCRL1 PTPRC KHDRBS2 TNFAIP8 BANK1	2.40e-05	171	89	5	8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CHST15 SIRPB2 FYB1 MEFV	2.40e-05	171	89	5	ef9397cec7f5c217d34583f26270af7ed7fbcebf
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 KHDRBS2 MUC16 ZNF804A ZEB2	2.47e-05	172	89	5	72fbfa890995e47048b47199c170cc7dcd7661f8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 KHDRBS2 MUC16 ZNF804A ZEB2	2.47e-05	172	89	5	2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCell	CTRL-Myeloid-Neutrophil\|CTRL / Disease state, Lineage and Cell class	ARAP3 PTPRC CHST15 SYNE2 MEFV	2.47e-05	172	89	5	ef3a6fe3b7300959f9f71130200c7fb8741c42b0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC SIRPB2 FYB1 ZNF804A ZEB2	2.47e-05	172	89	5	f6b4754a7e4b3e38030316a0ae00d932bfa87e41
Drug	Methamphetamine	CYP1A2 ARAP3 DST MAP2 SYNJ2 SWT1 BAZ2A ARHGEF1 MKI67 ASPM PSD3 ZBTB40 AKAP13 ATP1A1 USPL1 SLC14A2 DIS3 FKBP4 PRODH ABCB1 ITPR2	7.40e-08	1401	89	21	ctd:D008694
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	AHI1 BAZ2A ARHGEF1 KIAA0319L PSD3 YTHDC2 TSC22D4 AHNAK2	1.06e-06	197	89	8	3930_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	STK3 SYNJ2 ARHGEF1 MKI67 PSD3 YTHDC2 FKBP4	1.19e-05	196	89	7	6058_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	AHI1 SYNJ2 BAZ2A KIRREL1 TSC22D4 ODF2 FYB1	1.19e-05	196	89	7	4472_DN
Drug	NaCl	CYP1A2 DST NAPEPLD MAP2 HSPA4L PIK3C3 TNFAIP8 POLD3 ATP1A1 SLC14A2 PRODH	1.25e-05	564	89	11	CID000005234
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A	MAP2 SYNJ2 AKAP13 NUP188 TSC22D4 PRODH AHNAK2	1.32e-05	199	89	7	3570_UP
Drug	16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione	MAP2 TUT7 AKAP13 AHNAK2	2.88e-05	45	89	4	ctd:C020175
Drug	chrysene	CYP1A2 TCOF1 SYNE2 BRD7 MKI67 EXOC6B MUC16 FRMD4B ZFP62 AKAP12 SLC45A4 ABCB1 ITPR2	3.29e-05	871	89	13	ctd:C031180
Drug	MG-262; Up 200; 0.1uM; PC3; HT_HG-U133A	HSPA4L BAZ2A PRKD1 USPL1 ZNF804A FKBP4	4.08e-05	161	89	6	7068_UP
Drug	trabectedin	CYP1A2 MKI67 ABCB1	5.35e-05	19	89	3	ctd:C099150
Drug	flunixin meglumine	CYP1A2 ABCB1	9.02e-05	4	89	2	ctd:C014558
Drug	musk ketone	CYP1A2 ABCB1	9.02e-05	4	89	2	ctd:C031448
Drug	N-depropylpropafenone	CYP1A2 ABCB1	9.02e-05	4	89	2	CID000128820
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CYP1A2 AHI1 SYNJ2 EXOC6B PSD3 NUP188	9.36e-05	187	89	6	3278_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	BAZ2A ARHGEF12 AKAP13 YTHDC2 TSC22D4 DIS3	1.02e-04	190	89	6	5080_DN
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A	MAP2 SYNJ2 BAZ2A YTHDC2 FRMD4B ITPR2	1.11e-04	193	89	6	4725_UP
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	FBXO40 KHDRBS1 BAZ2A KIAA0319L AKAP12 ITPR2	1.14e-04	194	89	6	3680_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	ARHGAP5 ARHGAP32 GAPVD1 HSPA4L ZBTB40 FKBP4	1.18e-04	195	89	6	449_UP
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	FAM50B DHRS3 PSD3 ARHGEF12 DIS3 GPATCH2L	1.21e-04	196	89	6	7288_DN
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A	AHI1 DHRS3 SYNJ2 ZBTB40 ARHGEF12 FYB1	1.21e-04	196	89	6	2390_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ARHGEF1 KIAA0319L FYB1 GPATCH2L PRODH ITPR2	1.21e-04	196	89	6	6028_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A	STK3 CYP1A2 AHI1 KHDRBS2 FYB1 AKAP12	1.21e-04	196	89	6	7167_UP
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ARHGAP5 AHI1 KIAA0319L ARHGEF12 YTHDC2 NUP188	1.24e-04	197	89	6	4949_UP
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SYNJ2 ARHGEF1 NUP188 FYB1 BANK1 AHNAK2	1.24e-04	197	89	6	3581_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A	STK3 FBXO40 BAZ2A NUP188 TSC22D4 ITPR2	1.24e-04	197	89	6	4757_UP
Drug	nifedipine; Up 200; 10uM; MCF7; HG-U133A	ARAP3 BAZ2A EXOC6B FYB1 SLC4A5 ITPR2	1.24e-04	197	89	6	335_UP
Drug	Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A	STK3 BAZ2A KHDRBS2 AKAP13 ODF2 PRODH	1.24e-04	197	89	6	6453_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	AHI1 SYNJ2 ARHGEF1 PSD3 PRODH ITPR2	1.24e-04	197	89	6	4745_DN
Drug	U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A	CYP1A2 FBXO40 BAZ2A NUP188 ODF2 FYB1	1.28e-04	198	89	6	4553_UP
Drug	Milrinone [78415-72-2]; Up 200; 19uM; PC3; HT_HG-U133A	CCDC170 KHDRBS1 PSD3 FYB1 PRODH ITPR2	1.28e-04	198	89	6	5856_UP
Drug	Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A	BAZ2A PSD3 ZBTB40 YTHDC2 TNFAIP8 ITPR2	1.28e-04	198	89	6	7516_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	FAM50B SYNJ2 KIAA0319L GPATCH2L PRODH AHNAK2	1.28e-04	198	89	6	1519_UP
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	CYP1A2 SYNJ2 HSPA4L KIAA0319L ARHGEF12 AKAP13	1.28e-04	198	89	6	1868_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; PC3; HT_HG-U133A	ARHGAP32 BAZ2A ARHGEF12 YTHDC2 DIS3 GPATCH2L	1.28e-04	198	89	6	5083_DN
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A	BAZ2A AKAP13 TSC22D4 ODF2 DIS3 ITPR2	1.28e-04	198	89	6	1800_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	AHI1 KIAA0319L PSD3 DIS3 FRMD4B PRODH	1.28e-04	198	89	6	5242_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A	FAM50B ARAP3 BAZ2A ARHGEF1 KIAA0319L PSD3	1.32e-04	199	89	6	6740_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	CCDC170 ARHGAP32 AHI1 MKI67 ARHGEF12 AKAP13	1.32e-04	199	89	6	5283_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	ARHGAP5 ARHGAP32 PSD3 KIRREL1 AKAP13 GPATCH2L	1.32e-04	199	89	6	7292_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CYP1A2 KIAA0319L EXOC6B AKAP13 GPATCH2L PRODH	1.32e-04	199	89	6	3346_DN
Drug	Debrisoquin sulfate [581-88-4]; Down 200; 9uM; PC3; HT_HG-U133A	ZBTB40 KIRREL1 AKAP13 PRKD1 TSC22D4 FYB1	1.35e-04	200	89	6	6688_DN
Drug	Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A	ARHGAP32 SYNJ2 NFIC KIAA0319L DIS3 PRODH	1.35e-04	200	89	6	6789_DN
Drug	WY-14643; Up 200; 100uM; PC3; HG-U133A	ARHGAP32 SYNJ2 NFIC EXOC6B FYB1 SLC4A5	1.35e-04	200	89	6	481_UP
Disease	Colorectal Carcinoma	CYP1A2 ARAP3 MAP2 TCOF1 ARHGEF1 PCDH11X MKI67 PRKD1 POLD3 ZNF804A ZEB2 AKAP12 ABCB1	1.63e-07	702	88	13	C0009402
Disease	Schizophrenia	CYP1A2 ARHGAP32 AHI1 PIK3C3 PSD3 CMYA5 C9orf72 ADNP ZNF804A PRODH ABCB1	6.35e-05	883	88	11	C0036341
Disease	platelet component distribution width	CYP1A2 GAPVD1 BRD8 AHI1 PTPRC SYNJ2 BAZ2A AKAP13 TSC22D4 FYB1	8.48e-05	755	88	10	EFO_0007984
Disease	calcium measurement	FBXO40 SYNE2 KHDRBS2 PSD3 DTX3L ATP1A1 SUMO1P1 MYZAP BANK1	1.08e-04	628	88	9	EFO_0004838
Disease	Cerebellar Diseases	AHI1 ZEB2	1.83e-04	7	88	2	C0007760
Disease	CD5 antigen-like measurement	FCRL1 KIRREL1	1.83e-04	7	88	2	EFO_0020248
Disease	skin aging measurement	NFIC SYNE2 PSD3 PRKD1 AKAP12	2.13e-04	181	88	5	EFO_0008006
Disease	neutrophil count	AHI1 PTPRC PSD3 ARHGEF12 KIRREL1 AKAP13 TNFAIP8 ATP1A1 SAMD15 AKAP12 PRODH SLC45A4 ITPR2	2.24e-04	1382	88	13	EFO_0004833
Disease	advanced glycation end-product measurement	CYP1A2 PSD3	3.12e-04	9	88	2	EFO_0007819
Disease	familial Mediterranean fever (is_implicated_in)	MEFV ABCB1	3.12e-04	9	88	2	DOID:2987 (is_implicated_in)
Disease	Malignant neoplasm of breast	ARAP3 PTPRC SYNJ2 SYNE2 MKI67 DTX3L TSC22D4 ZEB2 AKAP12 PRODH ABCB1	3.49e-04	1074	88	11	C0006142
Disease	1-methylxanthine measurement	CYP1A2 PSD3	4.75e-04	11	88	2	EFO_0021174
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A2 PSD3	4.75e-04	11	88	2	EFO_0800951
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 TNFAIP8 MYZAP C9orf72	6.48e-04	131	88	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 TNFAIP8 MYZAP C9orf72	6.48e-04	131	88	4	C4552091
Disease	Juvenile arthritis	MAP2 TNFAIP8 MYZAP C9orf72	6.48e-04	131	88	4	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 TNFAIP8 MYZAP C9orf72	6.48e-04	131	88	4	C3714758
Disease	ovary epithelial cancer (is_marker_for)	BRD7 ASPM	6.71e-04	13	88	2	DOID:2152 (is_marker_for)
Disease	Juvenile-Onset Still Disease	MAP2 TNFAIP8 MYZAP C9orf72	7.26e-04	135	88	4	C0087031
Disease	response to platinum based chemotherapy, magnesium measurement	PSD3 PRKD1	9.00e-04	15	88	2	EFO_0004647, EFO_0004845
Disease	Colorectal Neoplasms	CYP1A2 MKI67 PRKD1 POLD3 ABCB1	1.46e-03	277	88	5	C0009404
Disease	BRCAX breast cancer	CCDC170 ITPR2	1.61e-03	20	88	2	EFO_0009443
Disease	Alzheimer disease, polygenic risk score	STK3 CCDC83 DST KHDRBS2 PSD3 ZNF804A WDPCP	1.86e-03	586	88	7	EFO_0030082, MONDO_0004975
Disease	soluble triggering receptor expressed on myeloid cells 2 measurement	PIK3C3 EXOC6B PRKD1 SUMO1P1 AKAP12	1.95e-03	296	88	5	EFO_0010151
Disease	Liver Cirrhosis, Experimental	CYP1A2 PTPRC DHRS3 MKI67 TNFAIP8 ZEB2 PRODH ABCB1	2.20e-03	774	88	8	C0023893
Disease	carotid artery intima media thickness	PSD3 ZBTB40 ZNF804A SLC14A2 FRMD4B PRODH	2.30e-03	450	88	6	EFO_0007117
Disease	nephrotic syndrome (implicated_via_orthology)	GAPVD1 KIRREL1	2.33e-03	24	88	2	DOID:1184 (implicated_via_orthology)
Disease	nevus count, cutaneous melanoma	NFIC SYNE2 AKAP12	2.58e-03	91	88	3	EFO_0000389, EFO_0004632
Disease	peripheral arterial disease, traffic air pollution measurement	AHI1 PRKD1 AKAP12 ITPR2	2.75e-03	194	88	4	EFO_0004265, EFO_0007908
Disease	gout	DST PSD3 POLD3 FRMD4B	2.85e-03	196	88	4	EFO_0004274

Protein segments in the cluster

Peptide	Gene	Start	Entry
MSDLEAKPSTEHLGD	SUMO1P1	1	G2XKQ0
METKHSPLEVGSESS	BANK1	466	Q8NDB2
LTEEPTKLMHNASDS	ADNP	941	Q9H2P0
LEEMQHTISTDEEKS	ARHGEF1	201	Q92888
TEEGSLDPKSDSAME	ARAP3	66	Q8WWN8
DEGHTRTLDTAKEME	BRD7	486	Q9NPI1
PLEAETQHKFEMSDS	BRD8	596	Q9H0E9
SNLHYMKETTSDDPD	AHI1	51	Q8N157
AHSDISKDMSEASEK	AKAP12	1626	Q02952
SGIHPDEAAEKEMTS	BAZ2A	211	Q9UIF9
VAKELPTDMELSAHD	AKAP13	1191	Q12802
TDPEMVEVHASSKEE	AKAP13	2306	Q12802
DDSSLDMSLKAFDHE	ASPM	1186	Q8IZT6
EMSLELPETHIEEKS	CCDC83	281	Q8IWF9
DRSAHLKVSVPDEMS	ARHGEF12	431	Q9NZN5
ESSDEMLSLVKNTHE	CYP1A2	211	P05177
GSPTEHEDVTVMDTK	ITPR2	956	Q14571
TIPSKLSDESAMDED	KIAA1107	661	Q9UPP5
LSDESAMDEDKHATA	KIAA1107	666	Q9UPP5
AMDEDKHATADSDVS	KIAA1107	671	Q9UPP5
ADESKSEIDALEMSS	ABCB1	641	P08183
QDESSDKEITHSVMD	DDI1	376	Q8WTU0
TSEIMTDTEKIHPSS	MUC16	9796	Q8WXI7
HSDTPETEETEMKAL	PRKD1	891	Q15139
MHSESELDSDDAIFT	KIAA0319L	1001	Q8IZA0
DIHVTGESEDMSAKE	DST	141	Q03001
HGSDLKDMTSEQLDD	ATP1A1	666	P05023
KDSVTSPDMDEITHG	GAPVD1	796	Q14C86
TENSHEDESPMKNVS	FYB1	206	O15117
MAKTPSDHLLSTLEE	MEFV	1	O15553
FSEDLHLSSTEVDDM	EXOC6B	511	Q9Y2D4
HTEESMTDDKITEVS	MKI67	1966	P46013
TPGHTEESMTDDKIT	MKI67	2446	P46013
PAAGHTEESMTDDKT	MKI67	2806	P46013
TMSERLHPSDDSIKV	PCDH11X	1306	Q9BZA7
MKSSVHSEEDDFVPE	ARHGAP32	41	A7KAX9
TVEHSVSVDKEPMAD	WDPCP	301	O95876
ESQSHLLSEMDSDKP	FRMD4B	696	Q9Y2L6
HPDKSRSEEDVQSMD	CHFR	366	Q96EP1
KEGHETPMDIDSDDS	DTX3L	521	Q8TDB6
AETLGTHMEDKVSLD	FCRL1	396	Q96LA6
EGKEIHSLMESESLL	CMYA5	2006	Q8N3K9
KSSRDMPDHSEEKEQ	CMYA5	2661	Q8N3K9
VLEKSSRDMPDHSEE	CMYA5	2746	Q8N3K9
DSETTLHENIMKETP	FBXO40	106	Q9UH90
SDSDDTMVAKRHPAL	GPATCH2L	86	Q9NWQ4
ELMAEKDSLDPSFTH	KHDRBS1	106	Q07666
EPLTMHSDREDDTAS	KIRREL1	546	Q96J84
MAEKDSLDPSFVHAS	KHDRBS2	11	Q5VWX1
LMSVKSELDTTEHEA	CCDC170	601	Q8IYT3
KAEASSGDHPTDTEM	FKBP4	426	Q02790
DPESFSEHMDDSKQE	CEP295	1981	Q9C0D2
DLEAPMDETHKESDL	SAMD15	121	Q9P1V8
LLSSMKSHSVPEEID	C9orf72	186	Q96LT7
SLMDSDDDALLKSQH	DHRS3	131	O75911
SDLSTEDDDSGHCKM	ODF2	106	Q5BJF6
HDTDADTALSLKDMV	MAP3K15	156	Q6ZN16
LHISMEDSGAEKENT	TAF8	256	Q7Z7C8
HDKDMEEDRASSSSG	SYNE2	4146	Q8WXH0
SMLAISGHLDSDDDS	TSC22D4	296	Q9Y3Q8
DSHSALSVLDVDGMK	SYNJ2	941	O15056
AEKPMDNSESSEESS	TCOF1	601	Q13428
MDKSGIDSLDHVTSD	TAF1D	1	Q9H5J8
MEDIKKAFPSHSESS	TAF1L	846	Q8IZX4
KPMDVEDSLELLSSH	PIK3C3	356	Q8NEB9
SPEEAEHKEMESCTS	PRODH	151	O43272
SSDKMSEIHTVLSEE	ARHGAP5	511	Q13017
TDSEEELNMKTSSVH	POLD3	411	Q15054
SMEIDLEDDVHSSSA	SWT1	366	Q5T5J6
MHSEAEESKEVATDV	TNFAIP8	1	O95379
RHKSGSMEEDVDTSP	NFIC	281	P08651
MDSETHDPIDLQTKE	DIS3	641	Q9Y2L1
SKPGHDLASMEDKTE	AHNAK2	5331	Q8IVF2
SLMDSENPSDTKEHH	CHST15	121	Q7LFX5
DIMRSKSDSALHVPD	SLC45A4	301	Q5BKX6
DGLSEHSEMKSDEGT	SIRPB2	131	Q5JXA9
SDEDELDSHTMVKTS	STK3	316	Q13188
EADTVDMATTKDPAT	USPL1	176	Q5W0Q7
DHSDAPMETETSFKN	HSPA4L	506	O95757
HSLALGSATEDKDSM	NUP188	1251	Q5SRE5
AHIDSLKMETETSAP	SLC4A5	901	Q9BY07
VHSIPEKLMDETTSE	PHF11	241	Q9UIL8
HDELEAPSMKTDTRT	VSTM1	121	Q6UX27
EHESLTMESLKADEG	MAP2	1136	P11137
PNDSSDSEMEDKTTA	YTHDC2	1086	Q9H6S0
MSHLKTSTEDEEPTE	ZFP62	1	Q8NB50
DDSSEDGKMETKSDH	ZEB2	1191	O60315
HKDLTSLETTSEMEA	TUT7	156	Q5VYS8
MPEEKDLRSSNEDSH	SLC14A2	46	Q15849
LEMSKESEHDSDESS	PTPRC	991	P08575
SHRDEKPAFSLDVSM	WDR87	1041	Q6ZQQ6
AHSEMGSTEILEKET	PSD3	556	Q9NYI0
DSHLESEHPKVMSTE	ZBTB40	1151	Q9NUA8
EHLEMETTSGELSDV	ZNF804A	896	Q7Z570
LLSDATMEKDESHAG	FAM50B	276	Q9Y247
MEKDHSSVPSSKEEL	NAPEPLD	86	Q6IQ20
LEHETEMSGELTDSD	MYZAP	321	P0CAP1